MindPortal Analysis: $5M Raised
What is MindPortal?
MindPortal builds non-invasive brain interface models for thought-to-text, AI chat, and GUI control. Its flagship systems include MindSpeech, MindGPT, and MindClick, each tied to specific metrics such as 30% open-vocabulary accuracy and under one second latency. The company says it has filed 13 patents, kept the team under 10 people, and spent less than $6 million building the foundation.
Location
London, United Kingdom
Employees
1-10
Founded
2019
Revenue
$5M
Product Features & Capabilities
- Non-invasive optical brain-computer interface, telepathic communication with AI, translates imagined speech to text, real-time dialogue with AI, decodes full sentences, thought-to-text interaction, functional near-infrared spectroscopy system, wearable devices for brain analysis, continuous mind-to-text model called MindSpeech.
How much MindPortal raised
Seed - $5 million
May 29, 2021Who are the founders of MindPortal
EA
Ekram Alam
Co-founder
JB
Jack Baber
Co-founder
Market Focus
MindPortal primarily focuses on the artificial intelligence (AI) industry, specifically enhancing communication between humans and AI through innovative models and technologies.
Investors
- Y Combinator
- Kleiner Perkins
- Learn Capital
- 12 other unnamed investors
Competitors Overview
MindPortal's main competitors in the AI communication and foundation model market include:
-
Kernel: Founded in 2016, Kernel has developed a screening platform for brain activity and has raised $158 million in funding. This significant financial backing allows Kernel to invest heavily in research and development, giving it an advantage in creating advanced technologies for brain-computer interfaces.
-
Cumulus Neuroscience: Established in 2015, Cumulus offers an AI and cloud-based brain physiology analysis tool specifically designed for clinical trials. With a total funding of $15.2 million, it focuses on providing insights into brain health, which may complement MindPortal's offerings.
-
BrainCheck: Founded in 2014, BrainCheck provides mobile games aimed at cognitive health tracking and has raised $36.8 million. Its focus on gamified cognitive assessments differentiates it from MindPortal's more research-driven approach.
-
C4 Therapeutics: This company operates in health diagnostics and focuses on therapeutic solutions, which may differ from MindPortal's emphasis on communication enhancement through AI.
-
Neosensory: Neosensory specializes in sensory augmentation devices, targeting a different aspect of human-AI interaction compared to MindPortal's focus on communication.
-
Injectsense: Another competitor in the wearable tech space, Injectsense focuses on health diagnostics, which may overlap with some of MindPortal's applications in AI and health.
Notable differences include Kernel's broader screening platform and larger funding, which may allow it to capture a larger market share compared to MindPortal. Additionally, each competitor has a unique approach to addressing neurological and sensory challenges, which sets them apart in the market.
See something that needs updating? Suggest edits to this profile.